High Court Quashes Second Complaint Against Drug Manufacturer Citing Double Jeopardy
In a landmark judgment, the High Court of Jammu & Kashmir and Ladakh at Srinagar has quashed criminal proceedings against Kumar Wanchoo, the Managing Director of Eaton Laboratories, citing the legal principle of ‘double jeopardy’. The court’s decision was announced on December 18, 2023, in a case involving the alleged manufacturing of a drug not meeting standard quality guidelines.
The judgment, pronounced by Justice Wasim Sadiq Nargal, revolves around two separate complaints against the same batch of a drug named Emlo-A, manufactured by Eaton Laboratories. The first complaint led to a conviction based on a confession by the accused, while the second, related to the same batch of the drug, was still pending.
In his observation, Justice Nargal stated, “This Court is of the view that if the prosecution in the second complaint against the Petitioner continues, then it will amount to allowing the Petitioner who has once been convicted, to be tried for the same offence again.” This key statement underlined the court’s rationale in applying the principle of double jeopardy, protected under Section 300 of the Criminal Procedure Code and Article 20(2) of the Constitution of India.
The court noted the similarity in both complaints – the same drug, Emlo-A, with the same batch number, manufacturing, and expiry dates. Despite the samples being collected from different locations and on different dates, the court found that the essence of the offence remained the same.
Further elaborating on the legal principle, Justice Nargal’s judgment reads, “The common principle of law laid down in Section 300 of Cr. P.C read with Article 20 (2) of the Constitution of India is that person once convicted or acquitted for commission of offence cannot be tried subsequently for the same offence.”
Date of Decision: 18.12.2023
Kumar Wanchoo VS State
